APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Alvimopan

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.

Types
Pharmaceutical Grade · Others
Applications
Pharmaceutical · Other

5 editions28 December 2025

View 5 research editions
$4,950Single user · USD · Market Analysis & ForecastExplore product: AlvimopanCompare research options for Alvimopan

Pharma & Healthcare

Human Albumin

Types
5% Concentrations · 25% Concentrations · Others
Applications
Component of Media · Drug Formulation & Vaccine · Therapeutics

5 editions22 December 2025

View 5 research editions
APO Research, Inc.